Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

    • Inizio leaders featured in Forbes’ ‘Voices of Oncology’ to drive innovation in cancer care

    September 24, 2025 |  

    Inizio experts contribute to Forbes’ Voices of Oncology, highlighting our commitment to driving innovation in cancer care through advanced data analytics, cross-sector collaboration, and real-world impact for patients.

    Voices-of-Oncology-Inizio

    With over 30 years of deep-rooted expertise in oncology, we partner with our clients at each pivotal moment in their journey, unlocking value through a connected suite of capabilities. Today, we’re proud to announce that a number of our leaders in Inizio have been featured in Forbes’ Voices of Oncology, a collaboration that reflects our commitment to advancing cancer care.

    Launching September 9, the ‘Voice of Innovation Partners’ chapter in Forbes’ ‘Voices of Oncology’ features contributions from:

    Accelerating innovation in oncology through collaboration, data & technology

    The ‘Voice of Innovation Partners’ chapter explores how innovation partners like Inizio harness advanced data analytics, cutting-edge technology, and cross-sector collaboration to:

    • Simplify complex challenges in oncology
    • Enhance decision-making across the cancer care continuum
    • Improve patient outcomes through real-world impact

    The book is a powerful collection of insights from global experts and thought leaders, offering a shared perspective on how we can work better together to shape the future of oncology. Voices of Oncology is an initiative of the Oncology Voice Network (OVN), a new platform built to spark connection, share knowledge, and amplify solutions across pharma, biotech, academia, and patient advocacy.

    Pre-order now: Forbes’ Voices of Oncology

    Available to pre-order now via Amazon – explore the Voices of Oncology here. If you’re looking for a partner who can turn knowledge into action and accelerate the journey from breakthrough science to real-world impact, learn more about us.

    This content was provided by Inizio

    Company Details

    - PMLiVE

    Inizio

    Email
    Website

     Latest Content from  Inizio 

    Event: Intellus Worldwide Summit 2019

    Visit us on stand number 311

    Blog: The Future of Food Allergy? The Emergence of Targeted Allergy Treatments

    Research Analyst Rachel Arthurs explores how public exposure to the complications of food allergy has affected attitudes toward treatment.In recent years, there has been a noticeable shift in the increased...

    News: Research Partnership is listed in the Alantra Pharma Fast 50 annual report

    The best performing privately-owned UK pharmaceutical businesses were revealed earlier this month with the publication of Pharma Times’ Alantra Pharma Fast 50 annual report.Read more about this report here

    Event: Blending data science and market research at the Data Analytics & Insight conference

    Last month Analytics Director Misti Paul attended the Data Analytics & Insight Conference. In our latest blog post she reflects on the presentations that were given and what lessons can be...

    Presentation: Optimize your digital assets with UX research

    US Director Liza Pliss recently presented the paper 'Optimize your digital assets with UX research' at the PMR Conference in New Jersey, USA. Don't worry if you missed it though,...

    Report: Living With Rheumatoid Arthritis 2019 reports now available to purchase

    We have published new Living with Rheumatoid Arthritis reports in 5EU, Japan and Canada. The reports consist of 30-minute quantitative online and qualitative telephone interviews with RA patients. Read more on...

    Infographic: Rheumatoid arthritis (RA)

    An overview of the RA biologic patientOur RA market snapshot offers an introduction to the real world patient data collected by our Therapy Watch RA study. The snapshot looks at...

    Webcast: Navigating new frontiers: Ways to find space in the future RA market

    In partnership with pharmaphorumView the webcast »The emergence of low-cost biosimilar versions of Humira and the new janus kinase (JAK) inhibitors, are shaking up a once-stable market.Although there are only...

    Live Webinar: China in the fast lane: How to play and win in the world’s hottest emerging market

    Tuesday 16th April 2019 10:00 EST/ 15:00 GMT / 16:00 CEST

    Pegasus expands Pharma team with senior hires

    Five new recruits support further growth of the Pharma & Life Sciences team